3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Gastrointestinal Stromal Tumors
1
Colorectal Neoplasms
1
Interventions
Imatinib Mesylate
3
nilotinib
2
Sunitinib
2
Ibandronic Acid
2
Doxorubicin
2
Cyclophosphamide
2
regorafenib
1
pegylated granulocyte colony-stimulating factor
1
nirogacestat
1
avapritinib
1
anlotinib
1
Zoledronic Acid
1
Tranexamic Acid
1
Thiotepa
1
Ritonavir
1
Radiotherapy
1
Pregabalin
1
Oxaliplatin
1
Nevirapine
1
Midazolam
1
Lopinavir
1
Lithium Carbonate
1
Lead
1
Kyphoplasty
1
Indocyanine Green
1
Ifosfamide
1
Hyperbaric Oxygenation
1
Filgrastim
1
Esomeprazole
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lead
×
Sarcoma
×
Clear all
NCT02800330
2018-08-02
REGORA
Erasmus Medical Center
Phase 4
Completed
31 enrolled